These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 25173538)

  • 21. The increasing detection of asymptomatic left ventricular dysfunction in patients with type 2 diabetes mellitus without overt cardiac disease: data from the SHORTWAVE study.
    Faden G; Faganello G; De Feo S; Berlinghieri N; Tarantini L; Di Lenarda A; Faggiano P; Cioffi G
    Diabetes Res Clin Pract; 2013 Sep; 101(3):309-16. PubMed ID: 23886659
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Influence of the treatment of the nodal reentrant tachycardia by RF catheter ablation on selected hemodynamic parameters of left ventricular systolic and diastolic function and exercise capacity].
    Lelakowski J; Dreher A
    Pol Merkur Lekarski; 2009 Jun; 26(156):600-4. PubMed ID: 19711724
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of lifestyle intervention in patients with type 2 diabetes: a meta-analysis.
    Chen L; Pei JH; Kuang J; Chen HM; Chen Z; Li ZW; Yang HZ
    Metabolism; 2015 Feb; 64(2):338-47. PubMed ID: 25467842
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of Low-Energy Diet or Exercise on Cardiovascular Function in Working-Age Adults With Type 2 Diabetes: A Prospective, Randomized, Open-Label, Blinded End Point Trial.
    Gulsin GS; Swarbrick DJ; Athithan L; Brady EM; Henson J; Baldry E; Argyridou S; Jaicim NB; Squire G; Walters Y; Marsh AM; McAdam J; Parke KS; Biglands JD; Yates T; Khunti K; Davies MJ; McCann GP
    Diabetes Care; 2020 Jun; 43(6):1300-1310. PubMed ID: 32220917
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of type 2 diabetes and duration of type 2 diabetes on cardiac structure and function.
    Jørgensen PG; Jensen MT; Mogelvang R; Fritz-Hansen T; Galatius S; Biering-Sørensen T; Storgaard H; Vilsbøll T; Rossing P; Jensen JS
    Int J Cardiol; 2016 Oct; 221():114-21. PubMed ID: 27423078
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bone mineral density is associated with left ventricular diastolic function in men with type 2 diabetes.
    Wang RT; Liu HT; Zhao YL; Li N; Liu T; Kong X; Yu KJ
    Diabetes Metab; 2016 Sep; 42(4):256-62. PubMed ID: 26971836
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Benefits of 1-Year Lifestyle Modification Program on Exercise Capacity and Diastolic Function Among Coronary Artery Disease Men With and Without Type 2 Diabetes.
    Piché ME; Poirier P; Marette A; Mathieu P; Lévesque V; Bibeau K; Larose É; Després JP
    Metab Syndr Relat Disord; 2019 Apr; 17(3):149-159. PubMed ID: 30789304
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interleukin-6 and activin A are independently associated with cardiovascular events and mortality in type 2 diabetes: the prospective Asker and Bærum Cardiovascular Diabetes (ABCD) cohort study.
    Ofstad AP; Gullestad L; Orvik E; Aakhus S; Endresen K; Ueland T; Aukrust P; Fagerland MW; Birkeland KI; Johansen OE
    Cardiovasc Diabetol; 2013 Aug; 12():126. PubMed ID: 23987834
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improvement of left ventricular function by lifestyle intervention in obesity: contributions of weight loss and reduced insulin resistance.
    Kosmala W; O'Moore-Sullivan T; Plaksej R; Przewlocka-Kosmala M; Marwick TH
    Diabetologia; 2009 Nov; 52(11):2306-2316. PubMed ID: 19727663
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiovascular Determinants of Aerobic Exercise Capacity in Adults With Type 2 Diabetes.
    Gulsin GS; Henson J; Brady EM; Sargeant JA; Wilmot EG; Athithan L; Htike ZZ; Marsh AM; Biglands JD; Kellman P; Khunti K; Webb D; Davies MJ; Yates T; McCann GP
    Diabetes Care; 2020 Sep; 43(9):2248-2256. PubMed ID: 32680830
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of waist circumference with impaired six-minute walk in type 2 diabetes mellitus is independent of cardiac function.
    Wang Y; Yang H; Nolan M; Negishi K; Burgess J; Marwick TH
    J Diabetes Complications; 2016 Apr; 30(3):542-4. PubMed ID: 26785712
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Progression of subclinical myocardial dysfunction in type 2 diabetes after 5 years despite improved glycemic control.
    Vintila VD; Roberts A; Vinereanu D; Fraser AG
    Echocardiography; 2012 Oct; 29(9):1045-53. PubMed ID: 22672221
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Left ventricular diastolic dysfunction: an early sign of diabetic cardiomyopathy?
    Cosson S; Kevorkian JP
    Diabetes Metab; 2003 Nov; 29(5):455-66. PubMed ID: 14631322
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effectiveness and cost of single and multi-factorial cardiovascular risk factor modification to guideline targets in type 2 diabetes.
    Prescott A; Bailey JE; Kelly KJ; Munyombwe T; Gray A; Summers LK
    Prim Care Diabetes; 2012 Apr; 6(1):67-73. PubMed ID: 22225755
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Indices of left heart ventricle relaxation after 5-months of hypotensive therapy with guanfacine].
    Kubasik A; Rynkiewicz A; Jaromczyk-Slisz J; Jasiel-Wojculewicz H; Krupa-Wojciechowska B
    Pol Tyg Lek; 1993 Jan 4-11; 48(1-2):15-8. PubMed ID: 8361874
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determinants of exercise capacity in patients with type 2 diabetes.
    Fang ZY; Sharman J; Prins JB; Marwick TH
    Diabetes Care; 2005 Jul; 28(7):1643-8. PubMed ID: 15983314
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exercise training and the cardiovascular consequences of type 2 diabetes and hypertension: plausible mechanisms for improving cardiovascular health.
    Stewart KJ
    JAMA; 2002 Oct; 288(13):1622-31. PubMed ID: 12350193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Left ventricular function and energy homeostasis in patients with type 1 diabetes with and without microvascular complications.
    Perseghin G; Lattuada G; De Cobelli F; Esposito A; Canu T; Ragogna F; Maffi P; Scifo P; Secchi A; Del Maschio A; Luzi L
    Int J Cardiol; 2012 Jan; 154(2):111-5. PubMed ID: 20926147
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myocardial dysfunction and cardiovascular disease in type 2 diabetes.
    Ofstad AP
    Scand J Clin Lab Invest; 2016 Jul; 76(4):271-81. PubMed ID: 27071642
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intensive versus standard multifactorial cardiovascular risk factor control in screen-detected type 2 diabetes: 5-year and longer-term modelled outcomes of the ADDITION-Leicester study.
    Webb D; Dales J; Zaccardi F; Hill S; Moore C; Farooqi A; Griffin S; Davies M; Khunti K
    Diabetes Metab Res Rev; 2019 Mar; 35(3):e3111. PubMed ID: 30521699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.